TIFFINI LASCH: Open Payments
NPI 1013650191 · DELAWARE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 35 payments from 12 companies in 2025. Trend: 2023 $935 · 2024 $1,667 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $145 |
| Janssen Pharmaceuticals, Inc | 2 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| LivaNova USA, Inc. | 3 | $75 |
| Lundbeck LLC | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
Products named: VRAYLAR, REXULTI, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, SPRAVATO, CAPLYTA, Auvelity, Qelbree, INGREZZA.
Industry payments across OH — which companies pay providers there.
